Paraneoplastic antibodies targeting intracellular antigens

Area of Science:

• Neurology
• Immunology
• Oncology

Background:

• Paraneoplastic neurologic syndromes (PNS) are rare neurological disorders associated with cancer.
• Diagnosis is often challenging and relies on identifying specific neural autoantibodies.
• PNS can manifest as distinct clinical syndromes like limbic encephalitis and cerebellar degeneration.

Approach:

• Analysis of neural autoantibodies in patient serum and cerebrospinal fluid (CSF).
• Categorization of antibodies targeting intracellular antigens versus cell surface epitopes.
• Correlation of antibody type with associated cancer types and clinical presentation.

Key Points:

• Intracellular autoantibodies are strongly associated with specific cancers (lung, breast, thymoma, gynecologic, testicular, neuroendocrine).
• These antibodies often indicate a robust immune response to small, contained tumors.
• Intracellular antibodies typically correlate with PNS that are less responsive to treatment, often seen in older individuals and smokers.

Conclusions:

• Identification of neural autoantibodies is crucial for diagnosing PNS.
• Understanding antibody targets (intracellular vs. cell surface) aids in predicting cancer association and treatment response.
• Advancements in technology and cancer immunotherapy are expanding the identification of novel autoantibodies.